- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 16-06-2026: General Updates
16-06-2026 | 06:39 pm
16-06-2026 | 06:39 pm
Zydus Lifesciences completed its acquisition of US specialty oncology firm Assertio Holdings for $166.33 million. Assertio, known for ROLVEDON® (2025 turnover $68.23 million), is now a wholly-owned subsidiary.
No comments yet. Be the first to comment!